Clinical Trials Logo

Restless Genital Syndrome clinical trials

View clinical trials related to Restless Genital Syndrome.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04566783 Completed - Clinical trials for Sexual Arousal Disorder

Identification of Etiopathological and Clinical Factors in Persistent Genital Arousal Disorder

iPGAD
Start date: June 1, 2020
Phase:
Study type: Observational

Investigation of (possible etiological) factors associated with PGAD symptomatology as well as description of comorbid disorders subjects with PGAD. Persistent genital arousal disorder (PGAD) is a presumably rare, although debilitating condition, which was first defined at the beginning of this century and has not yet found consideration by any of the international classification systems of diseases. PGAD is commonly characterized by persistent and unwanted sensations of genital arousal which are not related to subjective feelings of sexual desire or arousal. Affected patients which are predominantly women can suffer tremendously. The lack of basic research on the etiology of PGAD leads to insufficient therapeutical approaches.